Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Masimo Corp (MASI)

Masimo Corp (MASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,763,818
  • Shares Outstanding, K 54,948
  • Annual Sales, $ 937,840 K
  • Annual Income, $ 196,220 K
  • 60-Month Beta 0.87
  • Price/Sales 12.54
  • Price/Cash Flow 55.02
  • Price/Book 8.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.37
  • Number of Estimates 2
  • High Estimate 0.39
  • Low Estimate 0.35
  • Prior Year 0.76
  • Growth Rate Est. (year over year) -51.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
205.01 +4.43%
on 08/11/20
248.88 -13.98%
on 07/21/20
-10.26 (-4.57%)
since 07/14/20
3-Month
205.01 +4.43%
on 08/11/20
254.66 -15.93%
on 05/18/20
-32.03 (-13.01%)
since 05/14/20
52-Week
139.36 +53.62%
on 09/10/19
258.00 -17.02%
on 05/12/20
+66.71 (+45.26%)
since 08/14/19

Most Recent Stories

More News
Masimo PVi(R) Receives FDA Clearance as an Indicator of Fluid Responsiveness on Mechanically Ventilated Patients

Masimo (NASDAQ: MASI) today announced that PVi(R) has received FDA clearance as a continuous, noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult...

MASI : 214.09 (+0.07%)
Cerebral Somatic Oximeters Market Research Report by Type, by Patient Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ -- Read the full report: The Global Cerebral Somatic Oximeters Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.56%.Market Segmentation...

EW : 78.07 (-1.68%)
MASI : 214.09 (+0.07%)
MDT : 100.71 (-0.57%)
Smart Diagnostic Devices Help Ease the Burden on Healthcare Systems

, /PRNewswire/ -- Some of the most promising, high-growth-opportunity segments in the medical device market by application include surgical and infection control devices, general medical devices, cardiovascular...

DXCM : 425.16 (-2.32%)
ABT : 99.99 (-1.10%)
MASI : 214.09 (+0.07%)
LVGO : 118.34 (-1.43%)
Masimo Corp Set to Possibly Pullback After Yesterday's Rally of 2.82%

Masimo Corp (NASDAQ:MASI) traded in a range yesterday that spanned from a low of $215.21 to a high of $223.99. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of...

MASI : 214.09 (+0.07%)
New Blinded Observational Study Shows Greater Depth of Patient Sedation Than Intended During Procedural Colonoscopy

Masimo (NASDAQ: MASI) today announced that in a new study published in Anesthesia Research and Practice, researchers used Masimo SedLine(R) Brain Function Monitoring to investigate the depth of anesthesia...

MASI : 214.09 (+0.07%)
Masimo Named NBA Supplier of Pulse Oximetry

Masimo (NASDAQ: MASI) today announced that it has entered into a partnership with the National Basketball Association (NBA) to be its official supplier of pulse oximetry. As teams return to play, Masimo...

MASI : 214.09 (+0.07%)
Masimo (MASI) Earnings and Revenues Beat Estimates in Q2

Masimo (MASI) continues to gain from key Product segment, which witnessed solid growth in Q2.

MASI : 214.09 (+0.07%)
RMD : 176.78 (-0.41%)
OPK : 4.80 (-1.03%)
VRAY : 3.12 (-4.88%)
Masimo: 2Q Earnings Snapshot

IRVINE, Calif. (AP) _ Masimo Corp. (MASI) on Tuesday reported second-quarter profit of $55.8 million.

MASI : 214.09 (+0.07%)
Masimo (MASI) Surpasses Q2 Earnings and Revenue Estimates

Masimo (MASI) delivered earnings and revenue surprises of 8.97% and 4.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MASI : 214.09 (+0.07%)
Masimo Reports Second Quarter 2020 Financial Results

Masimo (Nasdaq: MASI) today announced its financial results for the second quarter ended June 27, 2020.

MASI : 214.09 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade MASI with:

Business Summary

Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare...

See More

Key Turning Points

2nd Resistance Point 218.87
1st Resistance Point 216.48
Last Price 214.09
1st Support Level 211.96
2nd Support Level 209.83

See More

52-Week High 258.00
Last Price 214.09
Fibonacci 61.8% 212.68
Fibonacci 50% 198.68
Fibonacci 38.2% 184.68
52-Week Low 139.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar